Mainolfi Nello Insider Trading Activity

Corporate InsiderCEO · CIK 1821189

16

Total trades

$21.2M

Total volume

Apr 29, 2026

Last activity

KYMR

Kymera Therapeutics, Inc.

Mainolfi Nello has been net-selling over the last 12 months with 0 purchases and 15 sales across 1 company.

KYMR is the most-traded position with 15 trades. The largest single transaction was a sale of KYMR for $8.9M on Dec 8, 2025.

Performance Scorecard

Forward stock performance after each transaction by Mainolfi Nello. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days+3.9%75%16
90 days-4.9%54%13
120 days-28.7%8%13

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

KYMR · Kymera Therapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Mainolfi Nello bought and sold KYMR.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
Apr 29, 2026
KYMRSell17,005$80.74$1.4M−2.4%CEO
Apr 29, 2026
KYMRSell12,059$81.70$985K−1.8%CEO
Apr 29, 2026
KYMRSell936$82.45$77K−0.1%CEO
Feb 25, 2026
KYMRSell19,764$89.78$1.8M−2.8%CEO
Feb 25, 2026
KYMRSell5,434$90.39$491K−0.8%CEO
Feb 25, 2026
KYMRSell3,293$91.76$302K−0.5%CEO
Feb 25, 2026
KYMRSell1,501$92.81$139K−0.2%CEO
Feb 25, 2026
KYMRSell8$93.49$747.92−0.0%CEO
Dec 31, 2025
KYMRSell23,986$77.95$1.9M−3.5%CEO
Dec 31, 2025
KYMRSell6,014$78.52$472K−0.9%CEO
Dec 8, 2025
KYMRSell100,000$89.17$8.9M−13.1%CEO
Oct 29, 2025
KYMRSell1,862$59.72$111K−0.3%CEO
Oct 29, 2025
KYMRSell24,511$61.02$1.5M−3.6%CEO
Oct 29, 2025
KYMRSell3,627$61.46$223K−0.5%CEO
Sep 16, 2025
KYMRSell30,000$49.00$1.5M−4.3%CEO
Jun 3, 2025
KYMRSell30,000$49.00$1.5M−4.3%CEO

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
KYMRKymera Therapeutics, Inc.16$21.2M

Other insiders at Kymera Therapeutics, Inc.

10 other tracked filers at KYMR.